Connect with us
Watch Jon Pilcher, CEO of Neuren Pharmaceuticals (ASX:NEU), speaking about Neuren’s area of drug focus and the latest updates on the Trofinetide development. 0:11 – Firstly,...
Watch Dr. Nina Webster, CEO and MD of Dimerix (ASX:DXB) and Jared Sim, Editor-in-Chief and Co-Founder of StockPal in this engaging Q&A with the following questions:...
Watch Michael Baker, Chief Executive Officer & Managing Director of SUDA Pharmaceuticals Ltd (ASX:SUD) and Jared Sim, Editor-in-Chief and Co-Founder of StockPal in this engaging Q&A...
Dr. Graham Kelly is the Executive Chairman, CEO and Founder of Noxopharm (ASX:NOX), an Australian publicly-listed clinical stage drug development company. The clinical stage drug candidate...
In this quick-fire style interview with the Executive Director, Michele Dilizia, Spark Plus discusses about the company, recent positive results for RECCE 327 in MRSA Burns...
In this quick-fire style interview with the Founder & CEO of Cannatrek, Tommy Huppert, Spark Plus discusses about the company, the medicinal cannabis industry as a...
In this quick-fire style interview with the Executive Chairman of PharmAust (ASX:PAA), Dr. Roger Aston, Spark Plus discusses the whole re-purposing of existing registered products in...
In this quick-fire style interview with the Chairman of Medical Kiwi, Aldo Miccio, Spark Plus discusses the background of the company, objectives in Asia as well...